Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on ...

A new brainwave test could detect early signs of Alzheimer’s years before diagnosis — in just three minutes. That’s according to researchers at the University of Bath and the University of Bristol, ...

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not. By Pam Belluck A blood test that can help diagnose Alzheimer’s disease has received ...

Alzheimer’s disease is currently diagnosed with expensive medical imaging or invasive methods that require a spinal tap. Patients now have an alternative. The FDA has cleared a new Fujirebio ...

Un électroencéphalogramme innovant pour détecter Alzheimer en amont Chaque année, la recherche contre la maladie d’Alzheimer dévoile de nouvelles pistes permettant une identification plus précoce des ...

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...

A simple at-home brainwave test can detect signs of memory impairment linked to Alzheimer's disease years before clinical diagnosis is typically possible. This feat has been demonstrated by ...

The blood test is nearly 92% as accurate as a PET scan or spinal tap in detecting patients with Alzheimer’s Getty The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

À 40–50 ans, un simple test sanguin des plaquettes pourrait-il signaler un risque de maladie d’Alzheimer des années avant les ...